Search - tctmd.com

Displaying 341 - 360 of 1463

Sort: Relevancy | Date

Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD

Presentation

Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD

Presenter: PA. Gurbel

December 16, 2015

News Daily News

他汀类药物对主动脉钙化的效果？影像学研究再次引发低密度脂蛋白在主动脉瓣疾病中作用的争论

December 16, 2015

News Daily News

¿Estatinas para el Manejo de la Calcificación Aórtica? Un Estudio de Imágenes Debate sobre el Papel de las LBD en la Enfermedad de la Válvula Aórtica

December 16, 2015

News Daily News

Statins for Aortic Calcification? Imaging Study Reopens Debate Over LDL’s Role in Aortic Valve Disease

December 16, 2015

News Daily News

依泽替米贝减少心血管事件的说法未能获得 FDA 顾问委员会的支持

Michael O'Riordan

December 15, 2015

News Daily News

Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV

Michael O'Riordan

December 15, 2015

News Industry News

First Patients Enrolled in the Gore RELINE MAX Clinical Study

December 15, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Daily News

研究表明 PCI 进展会削弱比伐卢定在出血风险方面的优势

December 14, 2015

News Daily News

研究肯定了 Watchman 左心耳封堵器减少卒中的成本效益

December 14, 2015

News Daily News

Un Estudio Confirma la Rentabilidad del Dispositivo Watchman para el Cierre del AAI en el Descenso de ACV

December 14, 2015

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

December 14, 2015

News Daily News

Según un Análisis los Beneficios Hemorrágico de la Bivalirudina Disminuyen a medida que Avanza la PCI

December 14, 2015

News Daily News

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Yael L. Maxwell

December 14, 2015

News Daily News

Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows

December 14, 2015

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presentation

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presenter: Vivek Y. Reddy

December 13, 2015

News Daily News

ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention

Michael O'Riordan

December 13, 2015

News Daily News

许多低收入患者在 PCI 后不能坚持使用氯吡格雷

December 10, 2015

News Daily News

Muchos Pacientes sin Recursos Dejan de Tomar Clopidogrel Post-PCI

December 10, 2015

News Daily News

Many Lower-Income Patients Fail to Stick With Clopidogrel After PCI

December 10, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.